Advertisement
News
Subscribe to MDT Magazine News

SME Announces 2011 International Honor Award Recipients

March 29, 2011 10:39 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., March 24, 2011 — The Society of Manufacturing Engineers (SME) announced today the recipients of the 2011 SME International Honor Awards recipients. These awards recognize those individuals who have made significant contributions to the field of manufacturing...

SME To Honor 12 Outstanding Young Engineers

March 29, 2011 10:39 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., March 29, 2011 — The Society of Manufacturing Engineers (SME) is pleased to recognize 12 individuals with Outstanding Young Manufacturing Engineer (OYME) awards. This award recognizes young manufacturing practitioners who have made exemplary contributions and...

GI Dynamics diabetic device shows positive study results

March 29, 2011 10:38 am | by Mass High Tech: The Journal of New England Technology | Comments

GI Dynamics Inc., a Lexington medical device firm, has announced results of three studies of its EndoBarrier Gastrointestinal Liner in treating type 2 diabetes and obesity.

Advertisement

Smoking in combination with immunosuppression poses greater risk for transplant-related carcinoma

March 29, 2011 9:40 am | by EurekAlert | Comments

(Wiley-Blackwell) Spanish researchers have found that liver transplant recipients who quit smoking have a lower incidence of smoking-related malignancies (SRM) than patients who keep smoking. In fact, SRMs were identified in 13.5 percent of deceased patients and smoking was...

TOPICS:

GSK and Valeant Receive European Authorisation for Trobalt (retigabine)

March 29, 2011 9:37 am | by Bio-Medicine.Org | Comments

LONDON and MISSISSAUGA, Ontario, March 29, 2011 /- GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) announced today that the European Commission has granted marketing authorisation for Trobalt™ (retigabine) as an adjunctive (add-on)...

TOPICS:

Promidian Survey Finds Growing Support for Patient-Centered Medical Home

March 29, 2011 9:37 am | by Bio-Medicine.Org | Comments

BERKELEY HEIGHTS, N.J., March 29, 2011 /- Promidian, a management consulting firm focused on the pharmaceutical and biotechnology industries, today announced top-line survey findings about the increasing interest in the patient-centered medical home (PCMH), a patient-centric...

TOPICS:

Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research

March 29, 2011 8:36 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, March 29, 2011 /- The Newborn Possibilities Fund , a grantmaking program established by Cord Blood Registry (CBR), today announced it will provide its first-ever grant to the Georgia Health Sciences University Foundation.  The university's medical center is conducting...

TOPICS:

Important Drug Information Notice Regarding Potassium Phosphates Injection, USP, 3 mM/mL Phosphorous; 4. 4 mEq/mL Potassium: 5 mL, 15 mL and 50 mL Single Dose Vials

March 29, 2011 8:35 am | by Bio-Medicine.Org | Comments

SHIRLEY, N.Y., March 29, 2011 /- Yesterday American Regent, Inc. issued a letter regarding a product recall from February 2011. The text of the letter follows: Dear Healthcare Professional, Recently, American Regent, Inc. recalled Potassium Phosphates Injection, USP, 5mL Single Dose Vial,...

TOPICS:
Advertisement

Important Drug Information Notice Regarding Sodium Thiosulfate Injection, USP, 10% (100mg/mL), 10mL Single Dose Vials and 25% (250mg/mL), 50mL Single Dose Vials

March 29, 2011 8:35 am | by Bio-Medicine.Org | Comments

SHIRLEY, N.Y., March 29, 2011 /- Yesterday American Regent, Inc. issued a letter regarding a product recall from February 2011. The text of the letter follows: Dear Healthcare Professional, Recently, American Regent, Inc. recalled Sodium Thiosulfate Injection, USP, 10%, 10mL Single Dose...

TOPICS:

New Analysis Finds Airport Scanner Risk Extremely Low

March 29, 2011 8:33 am | by Diagnostic Imaging | Comments

Are airport scanners safe? In another recent analysis on the topic, researchers at the University of California have estimated the cancer risk from one kind of scanners is extremely low.

TOPICS:

Interventional Radiologists: Y-90 Liver Cancer Treatment Effective

March 29, 2011 8:33 am | by Diagnostic Imaging | Comments

Interventional radiologists have confirmed the effectiveness of a liver cancer treatment that has shown results were chemotherapy has failed. Treating liver tumors with higher doses of intra-arterial yttrium-90 radioembolization, which can be done on an outpatient basis, was shown to be...

TOPICS:

MEDRAD® Announces New Head of Interventional Business

March 29, 2011 8:33 am | by Bio-Medicine.Org | Comments

WARRENDALE, Pa., March 29, 2011 /- Today MEDRAD, INC. announced that Jack Darby has joined the company as vice president of MEDRAD Interventional. In his new role, Darby will act as general manager of both the diagnostic and therapeutic lines of the business on a global scale, and will...

TOPICS:

Boston Scientific CEO pay package dropped in 2010

March 29, 2011 7:45 am | by MATTHEW PERRONE - AP Health Writer - Associated Press | Comments

Boston Scientific's Chief Executive Ray Elliott saw his compensation plummet in his first full year leading the company, as the device maker cut back on stock options and other bonuses granted when he first joined the company.The Natick, Mass.-based maker of heart implants paid Elliott a total...

Scientists Without Borders awards $10,000 to solvers of maternal health and nutrition challenge

March 29, 2011 7:39 am | by EurekAlert | Comments

(New York Academy of Sciences) Scientists Without Borders, a public/private partnership dedicated to developing, advancing, and sharing innovative approaches to solve pressing global development challenges, today announced three winning solutions in the $10,000 Scientists Without...

TOPICS:

X-Hero and Male Enhancer: Recall - Undeclared Drug Ingredient

March 29, 2011 7:30 am | by U.S. Food & Drug Administration | Comments

Products marketed as dietary supplement contain drug ingredients sulfosildenafil or tadalafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading